speb/financial-data huggingface dataset:
RERE balance_sheet (annual, 2023-12-31) — Investments And Advances: 467095000.00
RERE balance_sheet (annual, 2023-12-31) — Investments In Other Ventures Under Equity Method: 51097000.00
RERE balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 79449000.00
RERE cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
RERE cash_flow (annual, 2023-12-31) — Issuance Of Debt: 623915000.00
RERE balance_sheet (annual, 2023-12-31) — Leases: 139249000.00
RERE balance_sheet (annual, 2023-12-31) — Line Of Credit: 349931000.00
RERE balance_sheet (annual, 2023-12-31) — Loans Receivable: 122531000.00
RERE balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 22495000.00
RERE balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 22495000.00
RERE balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 130546000.00
RERE balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 106371000.00
RERE cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
RERE cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -160068000.00
RERE cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 10106000.00
RERE income_statement (annual, 2023-12-31) — Net Income: -156250000.00
RERE income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -156250000.00
RERE income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -156250000.00
RERE income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -156250000.00
RERE income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -156250000.00
RERE cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -156250000.00
RERE income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -156250000.00
RERE income_statement (annual, 2023-12-31) — Net Interest Income: 30819000.00
RERE cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 249481000.00
RERE cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 225949000.00
RERE income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 30819000.00
RERE cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 6472000.00
RERE balance_sheet (annual, 2023-12-31) — Net PPE: 148223000.00
RERE cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -83940000.00
RERE cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 0.00
RERE cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 225949000.00
RERE balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 3440830000.00
RERE balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 67658000.00
RERE balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 67658000.00
RERE income_statement (annual, 2023-12-31) — Normalized EBITDA: 192381000.00
RERE income_statement (annual, 2023-12-31) — Normalized Income: -156250000.00
RERE cash_flow (annual, 2023-12-31) — Operating Cash Flow: 243898000.00
RERE cash_flow (annual, 2023-12-31) — Operating Gains Losses: 65827000.00
RERE income_statement (annual, 2023-12-31) — Operating Income: -173338000.00
RERE income_statement (annual, 2023-12-31) — Operating Revenue: 12965782000.00
RERE balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 146323318.00
RERE balance_sheet (annual, 2023-12-31) — Other Current Assets: 27443000.00
RERE balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 228187000.00
RERE balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -16825000.00
RERE income_statement (annual, 2023-12-31) — Other Gand A: 265981000.00
RERE income_statement (annual, 2023-12-31) — Other Income Expense: -5887000.00
RERE balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 270631000.00
RERE cash_flow (annual, 2023-12-31) — Other Non Cash Items: 47075000.00
RERE balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 80411000.00
RERE income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -5887000.00
RERE income_statement (annual, 2023-12-31) — Other Operating Expenses: 1087730000.00
RERE balance_sheet (annual, 2023-12-31) — Other Payable: 102509000.00
RERE balance_sheet (annual, 2023-12-31) — Other Properties: 74834000.00
RERE balance_sheet (annual, 2023-12-31) — Other Receivables: 253107000.00
RERE balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 410547000.00
RERE income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
RERE balance_sheet (annual, 2023-12-31) — Payables: 782255000.00
RERE balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 951964000.00
RERE cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 0.00
RERE balance_sheet (annual, 2023-12-31) — Prepaid Assets: 251226000.00
RERE income_statement (annual, 2023-12-31) — Pretax Income: -148406000.00
RERE cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 2822000.00
RERE balance_sheet (annual, 2023-12-31) — Properties: 0.00
RERE cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 24672000.00
RERE cash_flow (annual, 2023-12-31) — Purchase Of Investment: -542698000.00
RERE cash_flow (annual, 2023-12-31) — Purchase Of PPE: -85183000.00
RERE balance_sheet (annual, 2023-12-31) — Receivables: 631652000.00
RERE balance_sheet (annual, 2023-12-31) — Receivables Adjustments Allowances: -16054000.00
RERE income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 10338870000.00
RERE income_statement (annual, 2023-12-31) — Reconciled Depreciation: 333731000.00
RERE cash_flow (annual, 2023-12-31) — Repayment Of Debt: -397966000.00
RERE cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -160068000.00
RERE income_statement (annual, 2023-12-31) — Research And Development: 195679000.00
RERE balance_sheet (annual, 2023-12-31) — Restricted Cash: 210000000.00
RERE balance_sheet (annual, 2023-12-31) — Retained Earnings: -9163134000.00
RERE cash_flow (annual, 2023-12-31) — Sale Of Business: 0.00
RERE cash_flow (annual, 2023-12-31) — Sale Of Investment: 792179000.00
RERE cash_flow (annual, 2023-12-31) — Sale Of PPE: 1243000.00
RERE income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 1250860000.00
RERE income_statement (annual, 2023-12-31) — Selling General And Administration: 1516841000.00
RERE balance_sheet (annual, 2023-12-31) — Share Issued: 158563781.00
RERE cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 623915000.00
RERE cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -397966000.00
RERE income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
RERE cash_flow (annual, 2023-12-31) — Stock Based Compensation: 134402000.00
RERE balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3711461000.00
RERE balance_sheet (annual, 2023-12-31) — Tangible Book Value: 3440830000.00
RERE income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
RERE income_statement (annual, 2023-12-31) — Tax Provision: -42530000.00
RERE income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.29
RERE balance_sheet (annual, 2023-12-31) — Taxes Receivable: 125663000.00
RERE balance_sheet (annual, 2023-12-31) — Total Assets: 5493079000.00
RERE balance_sheet (annual, 2023-12-31) — Total Capitalization: 3711461000.00
RERE balance_sheet (annual, 2023-12-31) — Total Debt: 405935000.00
RERE balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3711461000.00
RERE income_statement (annual, 2023-12-31) — Total Expenses: 13139120000.00
RERE balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1781618000.00
RERE balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 966360000.00
RERE balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 90153000.00
RERE income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -173338000.00
RERE balance_sheet (annual, 2023-12-31) — Total Tax Payable: 69421000.00
RERE income_statement (annual, 2023-12-31) — Total Unusual Items: 0.00
RERE income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 0.00
RERE balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 12240463.00
RERE balance_sheet (annual, 2023-12-31) — Treasury Stock: 377988000.00
RERE cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: 4773000.00
RERE balance_sheet (annual, 2023-12-31) — Working Capital: 2835254000.00
RERE income_statement (annual, 2024-12-31) — +Operating Expense: 3213013000.00
RERE income_statement (annual, 2024-12-31) — +Total Revenue: 16328400000.00
RERE balance_sheet (annual, 2024-12-31) — Accounts Payable: 171356000.00
RERE balance_sheet (annual, 2024-12-31) — Accounts Receivable: 58978000.00
RERE balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 58978000.00
RERE balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -249656000.00
RERE balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -249656000.00
RERE balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 13358237000.00
RERE balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 13358237000.00
RERE balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -2126000.00
RERE balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -2126000.00
RERE cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 11267000.00
RERE balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 402629000.00
RERE balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 402629000.00
RERE income_statement (annual, 2024-12-31) — Basic Average Shares: 244876968.00
RERE income_statement (annual, 2024-12-31) — Basic EPS: -0.03
RERE cash_flow (annual, 2024-12-31) — Beginning Cash Position: 2190696000.00
RERE balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 152342000.00
RERE balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 152342000.00
RERE cash_flow (annual, 2024-12-31) — Capital Expenditure: -59857000.00
RERE balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 129926000.00
RERE balance_sheet (annual, 2024-12-31) — Capital Stock: 953000.00
RERE balance_sheet (quarterly, 2024-12-31) — Capital Stock: 953000.00
RERE balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 1970183000.00
RERE balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 2553947000.00
RERE cash_flow (annual, 2024-12-31) — Cash Dividends Paid: 0.00
RERE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -307708000.00
RERE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -424401000.00
RERE cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 642807000.00
RERE cash_flow (annual, 2024-12-31) — Change In Account Payable: -360937000.00
RERE cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 76367000.00
RERE cash_flow (annual, 2024-12-31) — Change In Inventory: 461547000.00
RERE cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -1303000.00
RERE cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -51061000.00
RERE cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -79295000.00
RERE cash_flow (annual, 2024-12-31) — Change In Payable: -329239000.00
RERE cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -252872000.00
RERE cash_flow (annual, 2024-12-31) — Change In Receivables: -44280000.00
RERE cash_flow (annual, 2024-12-31) — Change In Working Capital: 32736000.00
RERE cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -4292000.00
RERE cash_flow (annual, 2024-12-31) — Changes In Cash: -89302000.00
RERE balance_sheet (annual, 2024-12-31) — Common Stock: 953000.00
RERE balance_sheet (quarterly, 2024-12-31) — Common Stock: 953000.00
RERE balance_sheet (annual, 2024-12-31) — Common Stock Equity: 3694552000.00
RERE cash_flow (annual, 2024-12-31) — Common Stock Payments: -184295000.00
RERE balance_sheet (annual, 2024-12-31) — Construction In Progress: 1693000.00
RERE balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 1693000.00
RERE income_statement (annual, 2024-12-31) — Cost Of Revenue: 13086418000.00
RERE balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 208383000.00
RERE balance_sheet (annual, 2024-12-31) — Current Assets: 4169356000.00
RERE balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 49992000.00
RERE balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 49992000.00
RERE balance_sheet (annual, 2024-12-31) — Current Debt: 225000000.00
RERE balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 274992000.00
RERE balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 0.00
RERE balance_sheet (quarterly, 2024-12-31) — Current Deferred Assets: 0.00
RERE balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 98834000.00
RERE balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 98834000.00
RERE balance_sheet (annual, 2024-12-31) — Current Liabilities: 1306991000.00
RERE balance_sheet (annual, 2024-12-31) — Current Provisions: 28403000.00
RERE balance_sheet (quarterly, 2024-12-31) — Current Provisions: 28403000.00
RERE cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 267063000.00
RERE cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 267063000.00
RERE income_statement (annual, 2024-12-31) — Diluted Average Shares: 244876968.00
RERE income_statement (annual, 2024-12-31) — Diluted EPS: -0.03
RERE income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -8229000.00
RERE balance_sheet (annual, 2024-12-31) — Duefrom Related Parties Current: 117161000.00
RERE balance_sheet (annual, 2024-12-31) — Dueto Related Parties Current: 109730000.00
RERE income_statement (annual, 2024-12-31) — EBIT: 14574000.00
RERE income_statement (annual, 2024-12-31) — EBITDA: 281637000.00
RERE income_statement (annual, 2024-12-31) — Earnings From Equity Interest Net Of Tax: -64664000.00
RERE cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 64664000.00
RERE cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 1289000.00
RERE cash_flow (annual, 2024-12-31) — End Cash Position: 2102683000.00
RERE cash_flow (annual, 2024-12-31) — Financing Cash Flow: -307708000.00
RERE cash_flow (annual, 2024-12-31) — Free Cash Flow: 582950000.00
RERE cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 3764000.00
RERE balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -9469000.00
RERE balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -9469000.00
RERE income_statement (annual, 2024-12-31) — General And Administrative Expense: 306782000.00
RERE balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 56603000.00
RERE balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 61104000.00
RERE balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 61104000.00
RERE balance_sheet (annual, 2024-12-31) — Gross PPE: 534012000.00
RERE balance_sheet (quarterly, 2024-12-31) — Gross PPE: 534012000.00
RERE income_statement (annual, 2024-12-31) — Gross Profit: 3241982000.00
RERE income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
RERE income_statement (annual, 2024-12-31) — Interest Expense: 15016000.00
RERE income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 15016000.00
RERE income_statement (annual, 2024-12-31) — Interest Income: 26861000.00
RERE income_statement (annual, 2024-12-31) — Interest Income Non Operating: 26861000.00
RERE cash_flow (annual, 2024-12-31) — Interest Paid Cff: 0.00
RERE cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 15016000.00
RERE balance_sheet (annual, 2024-12-31) — Inventory: 535070000.00
RERE balance_sheet (annual, 2024-12-31) — Invested Capital: 3919552000.00
RERE cash_flow (annual, 2024-12-31) — Investing Cash Flow: -424401000.00
RERE balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 402629000.00
RERE balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 402629000.00
RERE balance_sheet (annual, 2024-12-31) — Investments And Advances: 556136000.00
RERE balance_sheet (annual, 2024-12-31) — Investments In Other Ventures Under Equity Method: 75023000.00
RERE balance_sheet (quarterly, 2024-12-31) — Investments In Other Ventures Under Equity Method: 75023000.00
RERE balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 78484000.00
RERE balance_sheet (quarterly, 2024-12-31) — Investmentsin Associatesat Cost: 78484000.00
RERE cash_flow (annual, 2024-12-31) — Issuance Of Debt: 844627000.00
RERE balance_sheet (annual, 2024-12-31) — Leases: 155681000.00
RERE balance_sheet (quarterly, 2024-12-31) — Leases: 155681000.00
RERE balance_sheet (annual, 2024-12-31) — Line Of Credit: 225000000.00
RERE balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 225000000.00
RERE balance_sheet (annual, 2024-12-31) — Loans Receivable: 134463000.00
RERE balance_sheet (quarterly, 2024-12-31) — Loans Receivable: 134463000.00
RERE balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 79934000.00
RERE balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 79934000.00
RERE balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 153507000.00
RERE balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 153507000.00
RERE balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 134690000.00
RERE balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 134690000.00
RERE cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
RERE cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -184295000.00
RERE cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 3000000.00
RERE income_statement (annual, 2024-12-31) — Net Income: -8229000.00
RERE income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -8229000.00
RERE income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -8229000.00
RERE income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -8229000.00
RERE income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -8229000.00
RERE cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -8229000.00
RERE income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -8229000.00
RERE income_statement (annual, 2024-12-31) — Net Interest Income: 11845000.00
RERE cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -361816000.00
RERE cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -124931000.00
RERE income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 11845000.00
RERE cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -4253000.00
RERE balance_sheet (annual, 2024-12-31) — Net PPE: 284356000.00
RERE cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -58332000.00
RERE cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -124931000.00
RERE balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 3637949000.00
RERE balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 9244000.00
RERE balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 9244000.00
RERE balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 0.00
RERE balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 0.00
RERE income_statement (annual, 2024-12-31) — Normalized EBITDA: 281637000.00
RERE income_statement (annual, 2024-12-31) — Normalized Income: -8229000.00
RERE cash_flow (annual, 2024-12-31) — Operating Cash Flow: 642807000.00
RERE cash_flow (annual, 2024-12-31) — Operating Gains Losses: 71428000.00
RERE income_statement (annual, 2024-12-31) — Operating Income: 28969000.00
RERE income_statement (annual, 2024-12-31) — Operating Revenue: 16328400000.00
RERE balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 146551552.00
RERE balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 146551552.00
RERE balance_sheet (annual, 2024-12-31) — Other Current Assets: 23003000.00
RERE balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 23003000.00
RERE balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 240727000.00
RERE balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 240727000.00
RERE balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -9469000.00
RERE balance_sheet (quarterly, 2024-12-31) — Other Equity Adjustments: -9469000.00
RERE income_statement (annual, 2024-12-31) — Other Gand A: 306782000.00
RERE income_statement (annual, 2024-12-31) — Other Income Expense: -41256000.00
RERE balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 56603000.00
RERE balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 56603000.00
RERE cash_flow (annual, 2024-12-31) — Other Non Cash Items: 53061000.00
RERE balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 24270000.00
RERE income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -41256000.00
RERE income_statement (annual, 2024-12-31) — Other Operating Expenses: 1328839000.00
RERE balance_sheet (annual, 2024-12-31) — Other Payable: 78834000.00
RERE balance_sheet (quarterly, 2024-12-31) — Other Payable: 78834000.00
RERE balance_sheet (annual, 2024-12-31) — Other Properties: 89606000.00
RERE balance_sheet (quarterly, 2024-12-31) — Other Properties: 89606000.00
RERE balance_sheet (annual, 2024-12-31) — Other Receivables: 233133000.00
RERE balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 583764000.00
RERE balance_sheet (annual, 2024-12-31) — Payables: 455652000.00
RERE balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 664035000.00
RERE balance_sheet (annual, 2024-12-31) — Prepaid Assets: 279410000.00
RERE balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 279410000.00
RERE income_statement (annual, 2024-12-31) — Pretax Income: -442000.00
RERE cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 1518000.00
RERE balance_sheet (annual, 2024-12-31) — Properties: 0.00
RERE balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
RERE cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 13147000.00
RERE cash_flow (annual, 2024-12-31) — Purchase Of Investment: -571816000.00
RERE cash_flow (annual, 2024-12-31) — Purchase Of PPE: -59857000.00
RERE balance_sheet (annual, 2024-12-31) — Receivables: 645926000.00
RERE balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -15683000.00
RERE balance_sheet (quarterly, 2024-12-31) — Receivables Adjustments Allowances: -15683000.00
RERE income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 13086418000.00
RERE income_statement (annual, 2024-12-31) — Reconciled Depreciation: 267063000.00
RERE cash_flow (annual, 2024-12-31) — Repayment Of Debt: -969558000.00
RERE cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -184295000.00
RERE income_statement (annual, 2024-12-31) — Research And Development: 210364000.00
RERE balance_sheet (annual, 2024-12-31) — Restricted Cash: 132000000.00
RERE balance_sheet (annual, 2024-12-31) — Retained Earnings: -9171363000.00
RERE balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -9171363000.00
RERE cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
RERE cash_flow (annual, 2024-12-31) — Sale Of Investment: 210000000.00
RERE cash_flow (annual, 2024-12-31) — Sale Of PPE: 1525000.00
RERE income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1367028000.00
RERE income_statement (annual, 2024-12-31) — Selling General And Administration: 1673810000.00
RERE balance_sheet (annual, 2024-12-31) — Share Issued: 162991454.00
RERE balance_sheet (quarterly, 2024-12-31) — Share Issued: 162991454.00
RERE cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 844627000.00
RERE cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -969558000.00
RERE income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
RERE cash_flow (annual, 2024-12-31) — Stock Based Compensation: 166741000.00
RERE balance_sheet (annual, 2024-12-31) — Stockholders Equity: 3694552000.00
RERE balance_sheet (annual, 2024-12-31) — Tangible Book Value: 3637949000.00
RERE income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
RERE income_statement (annual, 2024-12-31) — Tax Provision: -56877000.00
RERE income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.25
RERE balance_sheet (annual, 2024-12-31) — Taxes Receivable: 117874000.00
RERE balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 117874000.00
RERE balance_sheet (annual, 2024-12-31) — Total Assets: 5090721000.00
RERE balance_sheet (annual, 2024-12-31) — Total Capitalization: 3694552000.00
RERE balance_sheet (annual, 2024-12-31) — Total Debt: 354926000.00
RERE balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 3694552000.00
RERE income_statement (annual, 2024-12-31) — Total Expenses: 16299431000.00
RERE balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1396169000.00
RERE balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 921365000.00
RERE balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 89178000.00
RERE income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 28969000.00
RERE balance_sheet (annual, 2024-12-31) — Total Tax Payable: 95732000.00
RERE balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 95732000.00
RERE income_statement (annual, 2024-12-31) — Total Unusual Items: 0.00
RERE income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
RERE balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 16439902.00
RERE balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 16439902.00
RERE balance_sheet (annual, 2024-12-31) — Treasury Stock: 483806000.00
RERE balance_sheet (quarterly, 2024-12-31) — Treasury Stock: 483806000.00
RERE cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 35593000.00
RERE balance_sheet (annual, 2024-12-31) — Working Capital: 2862365000.00
RERE income_statement (quarterly, 2025-03-31) — +Operating Expense: 964841000.00
RERE income_statement (quarterly, 2025-03-31) — +Total Revenue: 4653445000.00
RERE balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 152492000.00
RERE income_statement (quarterly, 2025-03-31) — Basic Average Shares: 244505505.00
RERE income_statement (quarterly, 2025-03-31) — Basic EPS: 0.18
RERE balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 76383000.00
RERE balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1809162000.00
RERE balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2387054000.00
RERE balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3741751000.00
RERE income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 3615916000.00
RERE balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 730761000.00
RERE balance_sheet (quarterly, 2025-03-31) — Current Assets: 4469907000.00
RERE balance_sheet (quarterly, 2025-03-31) — Current Debt: 281000000.00
RERE balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 281000000.00
RERE balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 228264000.00
RERE balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 228264000.00
RERE balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1532303000.00
RERE income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 246316065.00
RERE income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.17
RERE income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 42800000.00
RERE balance_sheet (quarterly, 2025-03-31) — Duefrom Related Parties Current: 253313000.00
RERE balance_sheet (quarterly, 2025-03-31) — Dueto Related Parties Current: 139786000.00
RERE income_statement (quarterly, 2025-03-31) — EBIT: 74575000.00
RERE income_statement (quarterly, 2025-03-31) — EBITDA: 74575000.00
RERE income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest Net Of Tax: -23620000.00
RERE income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 63374000.00
RERE balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 30124000.00
RERE income_statement (quarterly, 2025-03-31) — Gross Profit: 1037529000.00
RERE income_statement (quarterly, 2025-03-31) — Interest Expense: 1885000.00
RERE income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1885000.00
RERE income_statement (quarterly, 2025-03-31) — Interest Income: 8374000.00
RERE income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 8374000.00
RERE balance_sheet (quarterly, 2025-03-31) — Inventory: 736219000.00
RERE balance_sheet (quarterly, 2025-03-31) — Invested Capital: 281000000.00
RERE balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 523326000.00
RERE balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 76383000.00
RERE balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 76383000.00
RERE income_statement (quarterly, 2025-03-31) — Net Income: 42800000.00
RERE income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 42800000.00
RERE income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 42800000.00
RERE income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 42800000.00
RERE income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 42800000.00
RERE income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 42800000.00
RERE income_statement (quarterly, 2025-03-31) — Net Interest Income: 6489000.00
RERE income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 6489000.00
RERE balance_sheet (quarterly, 2025-03-31) — Net PPE: 177397000.00
RERE balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3711627000.00
RERE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 5272000.00
RERE balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 5272000.00
RERE income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 74575000.00
RERE income_statement (quarterly, 2025-03-31) — Normalized Income: 42800000.00
RERE income_statement (quarterly, 2025-03-31) — Operating Income: 72688000.00
RERE income_statement (quarterly, 2025-03-31) — Operating Revenue: 4653445000.00
RERE balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 146551552.00
RERE income_statement (quarterly, 2025-03-31) — Other Gand A: 63374000.00
RERE income_statement (quarterly, 2025-03-31) — Other Income Expense: -6487000.00
RERE balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 154955000.00
RERE income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -6487000.00
RERE income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 427605000.00
RERE balance_sheet (quarterly, 2025-03-31) — Other Receivables: 993321000.00
RERE balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 577892000.00
RERE balance_sheet (quarterly, 2025-03-31) — Payables: 292278000.00
RERE balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1023039000.00
RERE income_statement (quarterly, 2025-03-31) — Pretax Income: 72690000.00
RERE balance_sheet (quarterly, 2025-03-31) — Receivables: 1246634000.00
RERE income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 3615916000.00
RERE income_statement (quarterly, 2025-03-31) — Research And Development: 55004000.00
RERE balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 100000000.00
RERE income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 418858000.00
RERE income_statement (quarterly, 2025-03-31) — Selling General And Administration: 482232000.00
RERE balance_sheet (quarterly, 2025-03-31) — Share Issued: 146551552.00
RERE balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3741751000.00
RERE balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3711627000.00
RERE income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
RERE income_statement (quarterly, 2025-03-31) — Tax Provision: 6270000.00
RERE income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.09
RERE balance_sheet (quarterly, 2025-03-31) — Total Assets: 5355709000.00
RERE balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3741751000.00
RERE balance_sheet (quarterly, 2025-03-31) — Total Debt: 357383000.00
RERE balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3741751000.00
RERE income_statement (quarterly, 2025-03-31) — Total Expenses: 4580757000.00
RERE balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1613958000.00
RERE balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 885802000.00
RERE balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 81655000.00
RERE income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 72688000.00
RERE balance_sheet (quarterly, 2025-03-31) — Working Capital: 2937604000.00
RERE income_statement (quarterly, 2025-06-30) — +Operating Expense: 942840000.00
RERE income_statement (quarterly, 2025-06-30) — +Total Revenue: 4991465000.00
RERE balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 139976000.00
RERE income_statement (quarterly, 2025-06-30) — Basic Average Shares: 244676586.00
RERE income_statement (quarterly, 2025-06-30) — Basic EPS: 0.30
RERE balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 73209000.00
RERE balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1299051000.00
RERE balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1924756000.00
RERE balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3792689000.00
RERE income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 3957556000.00
RERE balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 769768000.00
RERE balance_sheet (quarterly, 2025-06-30) — Current Assets: 4303949000.00
RERE balance_sheet (quarterly, 2025-06-30) — Current Debt: 171000000.00
RERE balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 171000000.00
RERE balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 104222000.00
RERE balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 104222000.00
RERE balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1331824000.00
RERE income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 246322158.00
RERE income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.29
RERE income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 72336000.00
RERE balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 406434000.00
RERE balance_sheet (quarterly, 2025-06-30) — Dueto Related Parties Current: 146858000.00
RERE income_statement (quarterly, 2025-06-30) — EBIT: 101419000.00
RERE income_statement (quarterly, 2025-06-30) — EBITDA: 101419000.00
RERE income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest Net Of Tax: -10028000.00
RERE income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 77521000.00
RERE balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 12211000.00
RERE income_statement (quarterly, 2025-06-30) — Gross Profit: 1033909000.00
RERE income_statement (quarterly, 2025-06-30) — Interest Expense: 1743000.00
RERE income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1743000.00
RERE income_statement (quarterly, 2025-06-30) — Interest Income: 5580000.00
RERE income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 5580000.00
RERE balance_sheet (quarterly, 2025-06-30) — Inventory: 814105000.00
RERE balance_sheet (quarterly, 2025-06-30) — Invested Capital: 171000000.00
RERE balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 526298000.00
RERE balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 73209000.00
RERE balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 73209000.00
RERE income_statement (quarterly, 2025-06-30) — Net Income: 72336000.00
RERE income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 72336000.00
RERE income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 72336000.00
RERE income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 72336000.00
RERE income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 72336000.00
RERE income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 72336000.00
RERE income_statement (quarterly, 2025-06-30) — Net Interest Income: 3837000.00
RERE income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 3837000.00
RERE balance_sheet (quarterly, 2025-06-30) — Net PPE: 197185000.00
RERE balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 3780478000.00
RERE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 2585000.00
RERE balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 2585000.00
RERE income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 101419000.00
RERE income_statement (quarterly, 2025-06-30) — Normalized Income: 72336000.00
RERE income_statement (quarterly, 2025-06-30) — Operating Income: 91069000.00
RERE income_statement (quarterly, 2025-06-30) — Operating Revenue: 4991465000.00
RERE income_statement (quarterly, 2025-06-30) — Other Gand A: 77521000.00
RERE income_statement (quarterly, 2025-06-30) — Other Income Expense: 4770000.00
RERE balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 160664000.00
RERE income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 4770000.00
RERE income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 395982000.00
RERE balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1054455000.00
RERE balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 625705000.00
RERE balance_sheet (quarterly, 2025-06-30) — Payables: 286834000.00
RERE balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1056602000.00
RERE income_statement (quarterly, 2025-06-30) — Pretax Income: 99676000.00
RERE balance_sheet (quarterly, 2025-06-30) — Receivables: 1460889000.00
RERE income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 3957556000.00
RERE income_statement (quarterly, 2025-06-30) — Research And Development: 62467000.00
RERE balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 104199000.00
RERE income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 406870000.00
RERE income_statement (quarterly, 2025-06-30) — Selling General And Administration: 484391000.00
RERE balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3792689000.00
RERE balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 3780478000.00
RERE income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
RERE income_statement (quarterly, 2025-06-30) — Tax Provision: 17312000.00
RERE income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.17
RERE balance_sheet (quarterly, 2025-06-30) — Total Assets: 5200307000.00
RERE balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3792689000.00
RERE balance_sheet (quarterly, 2025-06-30) — Total Debt: 244209000.00
RERE balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3792689000.00
RERE income_statement (quarterly, 2025-06-30) — Total Expenses: 4900396000.00
RERE balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1407618000.00
RERE balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 896358000.00
RERE balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 75794000.00
RERE income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 91069000.00
RERE balance_sheet (quarterly, 2025-06-30) — Working Capital: 2972125000.00
RERE income_statement (quarterly, 2025-09-30) — +Operating Expense: 934187000.00
RERE income_statement (quarterly, 2025-09-30) — +Total Revenue: 5149155000.00
RERE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 146268000.00
RERE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 244541398.00
RERE income_statement (quarterly, 2025-09-30) — Basic EPS: 0.37
RERE balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 76986000.00
RERE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1627654000.00
RERE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2174339000.00
RERE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 3888417000.00
RERE income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 4094190000.00
RERE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 838408000.00
RERE balance_sheet (quarterly, 2025-09-30) — Current Assets: 4383995000.00
RERE balance_sheet (quarterly, 2025-09-30) — Current Debt: 149800000.00
RERE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 149800000.00
RERE balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 79139000.00
RERE balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 79139000.00
RERE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1330033000.00
RERE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 246494986.00
RERE income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.37
RERE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 90817000.00
RERE balance_sheet (quarterly, 2025-09-30) — Duefrom Related Parties Current: 244445000.00
RERE balance_sheet (quarterly, 2025-09-30) — Dueto Related Parties Current: 116418000.00
RERE income_statement (quarterly, 2025-09-30) — EBIT: 126418000.00
RERE income_statement (quarterly, 2025-09-30) — EBITDA: 126418000.00
RERE income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest Net Of Tax: -17460000.00
RERE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 74147000.00
RERE balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 11432000.00
RERE income_statement (quarterly, 2025-09-30) — Gross Profit: 1054965000.00
RERE income_statement (quarterly, 2025-09-30) — Interest Expense: 1258000.00
RERE income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1258000.00
RERE income_statement (quarterly, 2025-09-30) — Interest Income: 5921000.00
RERE income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 5921000.00
RERE balance_sheet (quarterly, 2025-09-30) — Inventory: 698834000.00
RERE balance_sheet (quarterly, 2025-09-30) — Invested Capital: 149800000.00
RERE balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 514256000.00
RERE balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 76986000.00
RERE balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 76986000.00
RERE income_statement (quarterly, 2025-09-30) — Net Income: 90817000.00
RERE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 90817000.00
RERE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 90817000.00
RERE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 90817000.00
RERE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 90817000.00
RERE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 90817000.00
RERE income_statement (quarterly, 2025-09-30) — Net Interest Income: 4663000.00
RERE income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 4663000.00
RERE balance_sheet (quarterly, 2025-09-30) — Net PPE: 229671000.00
RERE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3876985000.00
RERE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 2469000.00
RERE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2469000.00
RERE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 126418000.00
RERE income_statement (quarterly, 2025-09-30) — Normalized Income: 90817000.00
RERE income_statement (quarterly, 2025-09-30) — Operating Income: 120778000.00
RERE income_statement (quarterly, 2025-09-30) — Operating Revenue: 5149155000.00
RERE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 146337408.00
RERE income_statement (quarterly, 2025-09-30) — Other Gand A: 74147000.00
RERE income_statement (quarterly, 2025-09-30) — Other Income Expense: -281000.00
RERE balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 158551000.00
RERE income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -281000.00
RERE income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 432326000.00
RERE balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1259709000.00
RERE balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 546685000.00
RERE balance_sheet (quarterly, 2025-09-30) — Payables: 262686000.00
RERE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1101094000.00
RERE income_statement (quarterly, 2025-09-30) — Pretax Income: 125160000.00
RERE balance_sheet (quarterly, 2025-09-30) — Receivables: 1504154000.00
RERE income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 4094190000.00
RERE income_statement (quarterly, 2025-09-30) — Research And Development: 63823000.00
RERE balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 6668000.00
RERE income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 363891000.00
RERE income_statement (quarterly, 2025-09-30) — Selling General And Administration: 438038000.00
RERE balance_sheet (quarterly, 2025-09-30) — Share Issued: 146337408.00
RERE balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 3888417000.00
RERE balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 3876985000.00
RERE income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
RERE income_statement (quarterly, 2025-09-30) — Tax Provision: 16883000.00
RERE income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.13
RERE balance_sheet (quarterly, 2025-09-30) — Total Assets: 5297905000.00
RERE balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 3888417000.00
RERE balance_sheet (quarterly, 2025-09-30) — Total Debt: 226786000.00
RERE balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 3888417000.00
RERE income_statement (quarterly, 2025-09-30) — Total Expenses: 5028377000.00
RERE balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1409488000.00
RERE balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 913910000.00
RERE balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 79455000.00
RERE income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 120778000.00
RERE balance_sheet (quarterly, 2025-09-30) — Working Capital: 3053962000.00
RERE income_statement (annual, 2025-12-31) — +Operating Expense: 3892099000.00
RERE income_statement (quarterly, 2025-12-31) — +Operating Expense: 1050231000.00
RERE income_statement (annual, 2025-12-31) — +Total Revenue: 21048256000.00
RERE income_statement (quarterly, 2025-12-31) — +Total Revenue: 6254191000.00
RERE balance_sheet (annual, 2025-12-31) — Accounts Payable: 335622000.00
RERE balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 335622000.00
RERE balance_sheet (annual, 2025-12-31) — Accounts Receivable: 131599000.00
RERE balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 131599000.00